Barclays PLC Buys 19,264 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Barclays PLC grew its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 319.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,298 shares of the company's stock after purchasing an additional 19,264 shares during the period. Barclays PLC owned about 0.10% of OrthoPediatrics worth $686,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Divisadero Street Capital Management LP purchased a new position in OrthoPediatrics in the 2nd quarter worth $514,000. Wellington Management Group LLP increased its holdings in shares of OrthoPediatrics by 16.2% in the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company's stock worth $23,944,000 after buying an additional 122,846 shares during the period. Harbor Capital Advisors Inc. lifted its stake in shares of OrthoPediatrics by 268.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company's stock valued at $6,692,000 after acquiring an additional 179,803 shares during the last quarter. Geode Capital Management LLC boosted its holdings in OrthoPediatrics by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 391,492 shares of the company's stock valued at $10,615,000 after acquiring an additional 7,972 shares during the period. Finally, International Assets Investment Management LLC grew its position in OrthoPediatrics by 2,610.8% during the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock worth $27,000 after acquiring an additional 966 shares during the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Trading Up 2.4 %

NASDAQ:KIDS traded up $0.63 during mid-day trading on Friday, reaching $27.16. 481,435 shares of the company's stock traded hands, compared to its average volume of 334,830. OrthoPediatrics Corp. has a 12-month low of $21.02 and a 12-month high of $35.99. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The company has a 50 day moving average price of $23.98 and a 200-day moving average price of $27.36. The firm has a market capitalization of $657.82 million, a price-to-earnings ratio of -22.08 and a beta of 1.14.

Analysts Set New Price Targets

Several analysts have weighed in on KIDS shares. Needham & Company LLC reiterated a "buy" rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research report on Tuesday. Truist Financial lowered their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating for the company in a report on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.